To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects
Clinical trial NCT06705998 · RECRUITING
Trial details
- NCT number
- NCT06705998
- Sponsor
- BAR Pharmaceuticals s.r.l.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2026-05-15
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.